Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,256,404
-$825,374 QoQ
Shares Held
176,761
-2.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#654
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WILKINS INVESTMENT COUNSEL INC holds $77,139,543 across 7 Drug Manufacturers - General names. PFE ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
244,471 | $31,414,523 | |
| 2 | NVS |
Novartis AG
|
111,067 | $17,406,420 | |
| 3 | JNJ |
Johnson & Johnson
|
66,797 | $16,964,434 | |
| 4 | PFE |
Pfizer Inc
This page
|
176,761 | $4,256,404 | |
| 5 | ABBV |
AbbVie Inc.
|
14,832 | $3,732,324 | |
| 6 | LLY |
ELI LILLY & Co
|
2,484 | $2,979,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,700 | $386,054 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,256,404 | 176,761 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,081,778 | 180,975 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,465,939 | 179,355 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,079,692 | 199,360 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $4,901,570 | 202,210 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,209,549 | 205,586 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,862,939 | 258,686 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,638,249 | 263,934 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,309,327 | 261,234 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $7,133,165 | 257,051 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,970,005 | 103,161 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,388,680 | 102,161 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,772,501 | 102,849 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,498,159 | 110,249 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $5,618,414 | 109,649 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,812,024 | 109,964 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,765,412 | 109,964 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,822,261 | 112,464 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $6,718,177 | 113,771 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,936,300 | 114,771 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,494,432 | 114,771 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,179,891 | 115,371 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,386,684 | 119,171 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $4,465,321 | 121,671 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,978,645 | 121,671 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,984,392 | 122,071 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||